ArticleCancer2025
Changes in patient-reported primary care engagement in and communication about survivorship care from initial breast cancer treatment to longer-term survivorship.
Article in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterizing primary care in breast cancer survivors after completion of cancer therapy.Cancer causes & control : CCC · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe objective of this study was to evaluate changes in primary care physicians' (PCPs') engagement and communication from initial breast cancer treatment through longer term survivorship and the patient characteristics associated with low PCP engagement and communication during longer term survivorship.
methodsThe iCanCare study is a longitudinal study of women who were diagnosed with breast cancer in 2014-2015 in the Los Angeles and Georgia Surveillance, Epidemiology and End Results registries. Women were surveyed during initial treatment (baseline) and again approximately 6 years later in survivorship (follow-up; overall N = 1412; 60% response rate; n = 825 after exclusions). Respondents were asked how informed their PCP was about their breast cancer care (engagement) and how often they talked with their PCP about their breast cancer care (communication). The authors evaluated changes in PCP engagement and communication from baseline to follow-up and identified patient characteristics associated with low engagement and communication at follow-up using weighted, multivariable-adjusted logistic regression.
resultsIn this population-based sample of 825 women, 39.5% reported worse PCP communication and 37.9% reported worse PCP engagement during longer term survivorship compared with initial treatment. Women who reported high baseline PCP engagement and communication were one half as likely to report low engagement and communication during longer term survivorship (adjusted odds ratio, 0.50 [95% confidence interval, 0.37-0.68] and 0.43 [95% confidence interval, 0.32-0.58], respectively) compared with women who reported low baseline PCP engagement and communication.
conclusionsMany breast cancer survivors experienced worsening PCP engagement and communication from initial treatment to longer term survivorship despite initially high reports. Promoting sustained PCP engagement and communication could be a promising strategy for improving survivorship care delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.